Back

Adipocytokines and risk of ischaemic events in acute coronary syndromes: an age-dependent relationship

1 September 2025 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Pathophysiology of ischaemic heart disease Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Francesco Bruno

A.O.U. Citta Della Salute E Della Scienza Di Torino Molinette, Turin (Italy)

7 More presentations in this session

Presentation thumbnail
Unlocking the inflammatory 'code' in multivessel coronary disease: pathological network mediated by the PCSK9-NLRP3 axis and a novel microcirculatory dysfunction prediction model
Professor C. Liu (Tianjin, CN)
Abstract Slides Video
Presentation thumbnail
Plasma lysozyme as surrogate biomarker for detection of coronary artery disease in patients without Standard Modifiable Cardiovascular Risk Factors (SMuRFless)
Doctor S. Fathieh (London, GB)
Abstract Slides Video
Presentation thumbnail
Understanding the underpinning of hypertriglyceridemia as a risk factor for atherosclerosis
Doctor M. Ferreira (Funchal, PT)
Abstract Slides Video
Presentation thumbnail
Xanthosine alleviates myocardial ischemia-reperfusion injury through attenuation of cardiomyocyte ferroptosis
Doctor Y. Xu (Nanjing, CN)
Abstract Slides Video
Presentation thumbnail
Pathology of medial calcification in coronary arteries
Doctor N. Nakamura (Isehara, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Pathophysiology of ischaemic heart disease

The Event

Event poster

ESC Congress 2025

1 September 2025 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Leptin and adiponectin independently predict a first-ever myocardial infarction with a sex difference.
thumbnail
Congress Session
Risk factors, predictive models, and clinical outcomes in acute coronary conditions
thumbnail
Congress Presentation
Elevated plasma adiponectin in risk of heart failure, atrial fibrillation, aortic valve stenosis, and myocardial infarction: observational and mendelian randomization studies

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources